BridgeBio to present infigratinib data at ESPE 2026
BridgeBio (BBIO) plans to present new data on oral infigratinib’s impact on medical complications in achondroplasia at the Annual ESPE Meeting 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.